Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway. (Q45944887)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2009

Language	Label	Description	Also known as
English	Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.	scientific article published in July 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

imatinib mesylate

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Masashi Narazaki

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Fumitaka Terabe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Masayasu Kitano

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Mari Kawai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Yusuke Kuwahara

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Toru Hirano

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Junsuke Arimitsu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Keisuke Hagihara

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Yoshihito Shima

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Toshio Tanaka

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ichiro Kawase

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Hajime Sano

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Modern Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

522-529

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Molecular and cellular basis of rheumatoid joint destruction

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Transforming growth factor-beta in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Imatinib as a paradigm of targeted therapies

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Transforming signals resulting from sustained activation of the PDGFbeta receptor in mortal human fibroblasts

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Maintained efficacy of the tyrosine kinase inhibitor imatinib mesylate in a patient with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-009-0193-X

21 January 2018

Identifiers

10.3109/S10165-009-0193-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19568828%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45944887&oldid=1584551616"